Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies-Reference-Cited by-同舟云学术

Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies

Published:2016-07-01 Issue:10 Volume:18 Page:1357-1366
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:NEUONC

Author:

Garber Sarah T.,Hashimoto Yuuri,Weathers Shiao-Pei,Xiu Joanne,Gatalica Zoran,Verhaak Roel G. W.,Zhou Shouhao,Fuller Gregory N.,Khasraw Mustafa,de Groot John,Reddy Sandeep K.,Spetzler David,Heimberger Amy B.

Funder

Dr. Marnie Rose Foundation

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/18/10/1357/

Reference37 articles.

1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2. Current concepts and management of glioblastoma

3. Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

4. PD-L1 expression and prognostic impact in glioblastoma

5. Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the role of RNA methylation in glioma: Mechanisms, prognostic biomarkers, and therapeutic targets;Cellular Signalling;2024-12

2. OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS–STING pathway to mediate GBM immune escape;Journal for ImmunoTherapy of Cancer;2024-04

3. Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidates for Immune Checkpoint Blockade?;Applied Immunohistochemistry & Molecular Morphology;2023-12-30

4. Primary Intracranial Gliosarcoma: Is It Really a Variant of Glioblastoma? An Update of the Clinical, Radiological, and Biomolecular Characteristics;Journal of Clinical Medicine;2023-12-22

5. Identification of molecular subtypes and a risk model based on inflammation-related genes in patients with low grade glioma;Heliyon;2023-12